Literature DB >> 11115855

Disruption of the mouse Necdin gene results in hypothalamic and behavioral alterations reminiscent of the human Prader-Willi syndrome.

F Muscatelli1, D N Abrous, A Massacrier, I Boccaccio, M Le Moal, P Cau, H Cremer.   

Abstract

Prader-Willi syndrome (PWS) is a complex neurogenetic disorder with considerable clinical variability that is thought in large part to be the result of a hypothalamic defect. PWS results from the absence of paternal expression of imprinted genes localized in the 15q11-q13 region; however, none of the characterized genes has so far been shown to be involved in the etiology of PWS. Here, we provide a detailed investigation of a mouse model deficient for NECDIN: Linked to the mutation, a neonatal lethality of variable penetrance is observed. Viable NECDIN: mutants show a reduction in both oxytocin-producing and luteinizing hormone-releasing hormone (LHRH)-producing neurons in hypothalamus. This represents the first evidence of a hypothalamic deficiency in a mouse model of PWS. NECDIN:-deficient mice also display increased skin scraping activity in the open field test and improved spatial learning and memory in the Morris water maze. The latter features are reminiscent of the skin picking and improved spatial memory that are characteristics of the PWS phenotype. These striking parallels in hypothalamic structure, emotional and cognitive-related behaviors strongly suggest that NECDIN is responsible for at least a subset of the multiple clinical manifestations of PWS.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11115855     DOI: 10.1093/hmg/9.20.3101

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  89 in total

1.  NSCL-1 and NSCL-2 synergistically determine the fate of GnRH-1 neurons and control necdin gene expression.

Authors:  Marcus Krüger; Karen Ruschke; Thomas Braun
Journal:  EMBO J       Date:  2004-10-07       Impact factor: 11.598

2.  First principles of Hamiltonian medicine.

Authors:  Bernard Crespi; Kevin Foster; Francisco Úbeda
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2014-03-31       Impact factor: 6.237

Review 3.  Genomic imprinting and the social brain.

Authors:  Anthony R Isles; William Davies; Lawrence S Wilkinson
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2006-12-29       Impact factor: 6.237

Review 4.  Brain-expressed imprinted genes and adult behaviour: the example of Nesp and Grb10.

Authors:  Claire L Dent; Anthony R Isles
Journal:  Mamm Genome       Date:  2013-08-24       Impact factor: 2.957

5.  Placental protection of the fetal brain during short-term food deprivation.

Authors:  Kevin D Broad; Eric B Keverne
Journal:  Proc Natl Acad Sci U S A       Date:  2011-08-02       Impact factor: 11.205

6.  An imprinted gene network that controls mammalian somatic growth is down-regulated during postnatal growth deceleration in multiple organs.

Authors:  Julian C Lui; Gabriela P Finkielstain; Kevin M Barnes; Jeffrey Baron
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2008-04-30       Impact factor: 3.619

7.  Temporal and spatial expression of a growth-regulated network of imprinted genes in growth plate.

Authors:  Anenisia C Andrade; Julian C Lui; Ola Nilsson
Journal:  Pediatr Nephrol       Date:  2009-11-10       Impact factor: 3.714

8.  Reactivation of maternal SNORD116 cluster via SETDB1 knockdown in Prader-Willi syndrome iPSCs.

Authors:  Estela Cruvinel; Tara Budinetz; Noelle Germain; Stormy Chamberlain; Marc Lalande; Kristen Martins-Taylor
Journal:  Hum Mol Genet       Date:  2014-04-23       Impact factor: 6.150

9.  Separate necdin domains bind ARNT2 and HIF1alpha and repress transcription.

Authors:  Eitan R Friedman; Chen-Ming Fan
Journal:  Biochem Biophys Res Commun       Date:  2007-08-29       Impact factor: 3.575

Review 10.  Oxytocin and vasopressin systems in genetic syndromes and neurodevelopmental disorders.

Authors:  S M Francis; A Sagar; T Levin-Decanini; W Liu; C S Carter; S Jacob
Journal:  Brain Res       Date:  2014-01-22       Impact factor: 3.252

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.